1075 related articles for article (PubMed ID: 9778245)
21. Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line.
Howells LM; Gallacher-Horley B; Houghton CE; Manson MM; Hudson EA
Mol Cancer Ther; 2002 Nov; 1(13):1161-72. PubMed ID: 12479697
[TBL] [Abstract][Full Text] [Related]
22. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
23. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells.
Nielsen-Preiss SM; Silva SR; Gillette JM
J Cell Biochem; 2003 Dec; 90(5):964-75. PubMed ID: 14624456
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells.
Persad S; Attwell S; Gray V; Delcommenne M; Troussard A; Sanghera J; Dedhar S
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3207-12. PubMed ID: 10716737
[TBL] [Abstract][Full Text] [Related]
25. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
[TBL] [Abstract][Full Text] [Related]
26. PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation.
Ghosh AK; Grigorieva I; Steele R; Hoover RG; Ray RB
Gene; 1999 Jul; 235(1-2):85-91. PubMed ID: 10415336
[TBL] [Abstract][Full Text] [Related]
27. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
28. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies.
Dahia PL; Aguiar RC; Alberta J; Kum JB; Caron S; Sill H; Marsh DJ; Ritz J; Freedman A; Stiles C; Eng C
Hum Mol Genet; 1999 Feb; 8(2):185-93. PubMed ID: 9931326
[TBL] [Abstract][Full Text] [Related]
29. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase.
Wang X; Gjörloff-Wingren A; Saxena M; Pathan N; Reed JC; Mustelin T
J Immunol; 2000 Feb; 164(4):1934-9. PubMed ID: 10657643
[TBL] [Abstract][Full Text] [Related]
30. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
31. [PTEN tumor suppressor: functions as a lipid phosphatase].
Maehama T; Dixon JE
Tanpakushitsu Kakusan Koso; 2000 Oct; 45(14):2405-14. PubMed ID: 11051842
[No Abstract] [Full Text] [Related]
32. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
33. Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation.
Oganesian A; Poot M; Daum G; Coats SA; Wright MB; Seifert RA; Bowen-Pope DF
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7563-8. PubMed ID: 12802008
[TBL] [Abstract][Full Text] [Related]
34. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
Maehama T; Dixon JE
J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
[TBL] [Abstract][Full Text] [Related]
35. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.
Wu X; Senechal K; Neshat MS; Whang YE; Sawyers CL
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15587-91. PubMed ID: 9861013
[TBL] [Abstract][Full Text] [Related]
36. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
37. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
38. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
39. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways.
Weng L; Brown J; Eng C
Hum Mol Genet; 2001 Feb; 10(3):237-42. PubMed ID: 11159942
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
